145 related articles for article (PubMed ID: 24632718)
1. Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation: reply.
Levy B
Shock; 2014 Apr; 41(4):362-4. PubMed ID: 24632718
[No Abstract] [Full Text] [Related]
2. Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation.
Jakob S
Shock; 2014 Apr; 41(4):362. PubMed ID: 24632717
[No Abstract] [Full Text] [Related]
3. Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation.
Perez P; Kimmoun A; Blime V; Levy B
Shock; 2014 Apr; 41(4):269-74. PubMed ID: 24509521
[TBL] [Abstract][Full Text] [Related]
4. Should we aim at high blood pressure targets in patients with cardiogenic shock?
Pereira AJ; De Backer D
Shock; 2014 Apr; 41(4):365-6. PubMed ID: 24430543
[No Abstract] [Full Text] [Related]
5. Ethical challenges in emergency medicine research.
Tucker AT
Shock; 2014 Apr; 41(4):367-8. PubMed ID: 24632719
[No Abstract] [Full Text] [Related]
6. [Problems in the treatment of cardiogenic shock].
Heublein B; Parsi RA
Dtsch Gesundheitsw; 1970 Apr; 25(16):732-7. PubMed ID: 4320726
[No Abstract] [Full Text] [Related]
7. Comparison of dopamine and norepinephrine in shock.
Lee J
N Engl J Med; 2010 Jun; 362(24):2328-9; author reply 2330-1. PubMed ID: 20560159
[No Abstract] [Full Text] [Related]
8. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction.
Jolly S; Newton G; Horlick E; Seidelin PH; Ross HJ; Husain M; Dzavik V
Am J Cardiol; 2005 Dec; 96(12):1617-20. PubMed ID: 16360345
[TBL] [Abstract][Full Text] [Related]
9. Shock in myocardial infarction--medical treatment.
Kuhn LA
Am J Cardiol; 1970 Dec; 26(6):578-87. PubMed ID: 4938984
[No Abstract] [Full Text] [Related]
10. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
Levy B; Clere-Jehl R; Legras A; Morichau-Beauchant T; Leone M; Frederique G; Quenot JP; Kimmoun A; Cariou A; Lassus J; Harjola VP; Meziani F; Louis G; Rossignol P; Duarte K; Girerd N; Mebazaa A; Vignon P;
J Am Coll Cardiol; 2018 Jul; 72(2):173-182. PubMed ID: 29976291
[TBL] [Abstract][Full Text] [Related]
11. Cardiogenic shock and its current treatment.
Willerson JT
Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757
[No Abstract] [Full Text] [Related]
12. Beneficial Effects of Norepinephrine Alone on Cardiovascular Function and Tissue Oxygenation in a Pig Model of Cardiogenic Shock.
Beurton A; Ducrocq N; Auchet T; Joineau-Groubatch F; Falanga A; Kimmoun A; Girerd N; Fay R; Vanhuyse F; Tran N; Levy B
Shock; 2016 Aug; 46(2):214-8. PubMed ID: 26849625
[TBL] [Abstract][Full Text] [Related]
13. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
[No Abstract] [Full Text] [Related]
14. Cardiogenic shock.
Loeb HS; Johnson SA; Gunnar RM
Triangle; 1974; 13(3):121-7. PubMed ID: 4614505
[No Abstract] [Full Text] [Related]
15. Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction.
Misra SN; Kezdi P
Am J Cardiol; 1973 Jun; 31(6):724-35. PubMed ID: 4145230
[No Abstract] [Full Text] [Related]
16. [Basic principles of the therapy of shock].
Schröder R
Minerva Med; 1972 Dec; 63(93):5243-6. PubMed ID: 4646406
[No Abstract] [Full Text] [Related]
17. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
Levy B; Perez P; Perny J; Thivilier C; Gerard A
Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
[TBL] [Abstract][Full Text] [Related]
18. Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine.
Krenn L; Delle Karth G
Crit Care Med; 2011 Mar; 39(3):583-4. PubMed ID: 21330855
[No Abstract] [Full Text] [Related]
19. Principle defects which account for shock following acute myocardial infarction in man: implications for treatment.
Mueller H; Ayres SM; Grace WJ
Crit Care Med; 1973; 1(1):27-38. PubMed ID: 4757962
[No Abstract] [Full Text] [Related]
20. Management of shock following acute myocardial infarction. Part I. Drug therapy.
Kuhn LA
Am Heart J; 1978 Apr; 95(4):529-34. PubMed ID: 636990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
